NuLens
Founded Year
2002Stage
Other Investors | DeadAbout NuLens
NuLens researches, develops and markets technologies for the ophthalmic markets. The company is currently developing a new Accommodative Intraocular Lens (IOL) technology with the potential to provide over 10 diopters of accommodative power. This exciting innovation, based on the patents of Dr. Joshua Ben Nun, will prove to be a intraocular lens to provide real, comfortable, and lasting accommodation for near, intermediate and far distances - the way nature intended. Not only does it restore eyesight, it aims to provide better eyesight than ever before. NuLens (is) one of a truly accommodating IOLs with accommodative amplitudes far in excess of any other current single or dual optic designs ( American Academy of Ophthalmology )
NuLens Patents
NuLens has filed 12 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
9/15/2014 | 11/14/2017 | Eye surgery, Ophthalmology, Vision, Corrective lenses, Sulci (neuroanatomy) | Grant |
Application Date | 9/15/2014 |
---|---|
Grant Date | 11/14/2017 |
Title | |
Related Topics | Eye surgery, Ophthalmology, Vision, Corrective lenses, Sulci (neuroanatomy) |
Status | Grant |
NuLens Frequently Asked Questions (FAQ)
When was NuLens founded?
NuLens was founded in 2002.
What is NuLens's latest funding round?
NuLens's latest funding round is Other Investors.
Who are the investors of NuLens?
Investors of NuLens include Warburg Pincus and Elron Ventures.